Pfizer, BioNTech’s U.S. supply deal price tag leaves room for ‘decent’ profit on COVID-19 shot: analyst

Pfizer, BioNTech’s U.S. supply deal price tag leaves room for ‘decent’ profit on COVID-19 shot: analyst
kblankenship
Thu, 07/23/2020 – 09:07